Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Fiprotec 67 mg V/DCP/14/0022 Beaphar B.V., Nīderlande QP53AX15 small dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija;Beaphar BV, Nīderlande
Date of authorisation/renewal: 08-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0022-01 67 mg 1 Pipete, 1 deva -
V/DCP/14/0022-02 67 mg 2 Pipete, 1 deva -
V/DCP/14/0022-03 67 mg 3 Pipete, 1 deva -
V/DCP/14/0022-04 67 mg 6 Pipete, 1 deva -
V/DCP/14/0022-07 67 mg 4 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0022-08 67 mg 1 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0022-09 67 mg 2 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0022-10 67 mg 3 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0022-11 67 mg 6 Pipete alumīnija blisterī, 1 deva -
Fiprotec 134 mg V/DCP/14/0023 Beaphar B.V., Nīderlande QP53AX15 medium dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija;Beaphar BV, Nīderlande
Date of authorisation/renewal: 08-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0023-01 134 mg 1 Pipete, 1 deva -
V/DCP/14/0023-02 134 mg 2 Pipete, 1 deva -
V/DCP/14/0023-03 134 mg 3 Pipete, 1 deva -
V/DCP/14/0023-04 134 mg 6 Pipete, 1 deva -
V/DCP/14/0023-07 134 mg 4 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0023-08 134 mg 1 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0023-09 134 mg 2 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0023-10 134 mg 3 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0023-11 134 mg 6 Pipete alumīnija blisterī, 1 deva -
Fiprotec 268 mg V/DCP/14/0024 Beaphar B.V., Nīderlande QP53AX15 large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija;Beaphar BV, Nīderlande
Date of authorisation/renewal: 08-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0024-01 268 mg 1 Pipete, 1 deva -
V/DCP/14/0024-02 268 mg 2 Pipete, 1 deva -
V/DCP/14/0024-03 268 mg 3 Pipete, 1 deva -
V/DCP/14/0024-04 268 mg 6 Pipete, 1 deva -
V/DCP/14/0024-07 268 mg 4 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0024-08 268 mg 1 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0024-09 268 mg 2 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0024-10 268 mg 3 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0024-11 268 mg 6 Pipete alumīnija blisterī, 1 deva -
Ungezieferband Katze 2.1 g V/NRP/01/1337 Beaphar B.V., Nīderlande QP53AF03 cats Vairāk

Medicinal product information

Pharmaceutical form: collar
International name (active substance): Dimpylate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Beaphar B.V., Nīderlande
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 07052018LI (07-May-2018)
Labelling text: [PDF] 07052018M (07-May-2018)
Summary of product characteristics: [PDF] 07052018ZA (07-May-2018)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1337-01 2,1 g 1 Papīra maisiņš, 1 deva -
Fiprotec 402 mg V/DCP/14/0025 Beaphar B.V., Nīderlande QP53AX15 very large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija;Beaphar BV, Nīderlande
Date of authorisation/renewal: 08-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0025-01 402 mg 1 Pipete, 1 deva -
V/DCP/14/0025-02 402 mg 2 Pipete, 1 deva -
V/DCP/14/0025-03 402 mg 3 Pipete, 1 deva -
V/DCP/14/0025-04 402 mg 6 Pipete, 1 deva -
V/DCP/14/0025-07 402 mg 4 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0025-08 402 mg 1 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0025-09 402 mg 2 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0025-10 402 mg 3 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0025-11 402 mg 6 Pipete alumīnija blisterī, 1 deva -
Ungezieferband Hund 3.9 g V/NRP/11/0043 Beaphar B.V., Nīderlande QP53AF03 dogs Vairāk

Medicinal product information

Pharmaceutical form: collar
International name (active substance): Dimpylate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Beaphar B.V., Nīderlande
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 07052018LI (07-May-2018)
Labelling text: [PDF] 07052018M (07-May-2018)
Summary of product characteristics: [PDF] 07052018ZA (07-May-2018)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/11/0043-01 3,9 g 1 Papīra maisiņš, 1 deva -
Metrovis 100 mg V/DCP/19/0042 Industrial Veterinaria, S.A., Spānija QJ01XD01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0042-01 100 mg 1 Blisteris, 10 tablete -
V/DCP/19/0042-02 100 mg 2 Blisteris, 10 tablete -
V/DCP/19/0042-03 100 mg 5 Blisteris, 10 tablete -
V/DCP/19/0042-04 100 mg 10 Blisteris, 10 tablete -
V/DCP/19/0042-05 100 mg 25 Blisteris, 10 tablete -
V/DCP/19/0042-06 100 mg 50 Blisteris, 10 tablete -
Metrovis 250 mg V/DCP/19/0043 Industrial Veterinaria, S.A., Spānija QJ01XD01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0043-01 250 mg 1 Blisteris, 10 tablete -
V/DCP/19/0043-02 250 mg 2 Blisteris, 10 tablete -
V/DCP/19/0043-03 250 mg 5 Blisteris, 10 tablete -
V/DCP/19/0043-04 250 mg 10 Blisteris, 10 tablete -
V/DCP/19/0043-05 250 mg 25 Blisteris, 10 tablete -
V/DCP/19/0043-06 250 mg 50 Blisteris, 10 tablete -
Canidryl 20 mg 20 mg V/MRP/08/1565 Chanelle Pharmaceuticals Manufacturing Limited, Īrija QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 07-Oct-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 230911LI (07-Oct-2011)
Labelling text: [PDF] 230911M (07-Oct-2011)
Summary of product characteristics: [PDF] 230911ZA (07-Oct-2011)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1565-01 20 mg 1 Blisteris, 6 tablete -
V/MRP/08/1565-02 20 mg 10 Blisteris, 10 tablete -
V/MRP/08/1565-03 20 mg 1 Blisteris, 10 tablete -
V/MRP/08/1565-04 20 mg 1 Blisteris, 14 tablete -
V/MRP/08/1565-05 20 mg 2 Blisteris, 10 tablete -
V/MRP/08/1565-06 20 mg 2 Blisteris, 14 tablete -
V/MRP/08/1565-07 20 mg 3 Blisteris, 10 tablete -
V/MRP/08/1565-08 20 mg 3 Blisteris, 14 tablete -
V/MRP/08/1565-09 20 mg 5 Blisteris, 10 tablete -
V/MRP/08/1565-10 20 mg 4 Blisteris, 14 tablete -
V/MRP/08/1565-11 20 mg 6 Blisteris, 10 tablete -
V/MRP/08/1565-12 20 mg 5 Blisteris, 14 tablete -
V/MRP/08/1565-13 20 mg 7 Blisteris, 10 tablete -
V/MRP/08/1565-14 20 mg 6 Blisteris, 14 tablete -
V/MRP/08/1565-15 20 mg 7 Blisteris, 14 tablete -
V/MRP/08/1565-16 20 mg 10 Blisteris, 14 tablete -
V/MRP/08/1565-17 20 mg 14 Blisteris, 10 tablete -
V/MRP/08/1565-18 20 mg 18 Blisteris, 10 tablete -
V/MRP/08/1565-19 20 mg 20 Blisteris, 10 tablete -
V/MRP/08/1565-20 20 mg 25 Blisteris, 10 tablete -
V/MRP/08/1565-21 20 mg 28 Blisteris, 10 tablete -
V/MRP/08/1565-22 20 mg 20 Blisteris, 14 tablete -
V/MRP/08/1565-23 20 mg 30 Blisteris, 10 tablete -
V/MRP/08/1565-24 20 mg 50 Blisteris, 10 tablete -
V/MRP/08/1565-25 20 mg 100 Blisteris, 10 tablete -
V/MRP/08/1565-26 20 mg 1 ABPE konteiners, 6 tablete -
V/MRP/08/1565-27 20 mg 1 ABPE konteiners, 10 tablete -
V/MRP/08/1565-28 20 mg 1 ABPE konteiners, 14 tablete -
V/MRP/08/1565-29 20 mg 1 ABPE konteiners, 20 tablete -
V/MRP/08/1565-30 20 mg 1 ABPE konteiners, 28 tablete -
V/MRP/08/1565-31 20 mg 1 ABPE konteiners, 30 tablete -
V/MRP/08/1565-32 20 mg 1 ABPE konteiners, 42 tablete -
V/MRP/08/1565-33 20 mg 1 ABPE konteiners, 50 tablete -
V/MRP/08/1565-34 20 mg 1 ABPE konteiners, 60 tablete -
V/MRP/08/1565-35 20 mg 1 ABPE konteiners, 70 tablete -
V/MRP/08/1565-36 20 mg 1 ABPE konteiners, 84 tablete -
V/MRP/08/1565-37 20 mg 1 ABPE konteiners, 98 tablete -
V/MRP/08/1565-38 20 mg 1 ABPE konteiners, 100 tablete -
V/MRP/08/1565-39 20 mg 1 ABPE konteiners, 140 tablete -
V/MRP/08/1565-40 20 mg 1 ABPE konteiners, 180 tablete -
V/MRP/08/1565-41 20 mg 1 ABPE konteiners, 200 tablete -
V/MRP/08/1565-42 20 mg 1 ABPE konteiners, 250 tablete -
V/MRP/08/1565-43 20 mg 1 ABPE konteiners, 280 tablete -
V/MRP/08/1565-44 20 mg 1 ABPE konteiners, 300 tablete -
V/MRP/08/1565-45 20 mg 1 ABPE konteiners, 500 tablete -
V/MRP/08/1565-46 20 mg 1 ABPE konteiners, 1000 tablete -
Canidryl 100 mg 100 mg V/MRP/08/1567 Chanelle Pharmaceuticals Manufacturing Limited, Īrija QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 07-Oct-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOC] 230320LI (23-Mar-2020)
Labelling text: [DOC] 230320M (23-Mar-2020)
Summary of product characteristics: [DOC] 230320ZA (23-Mar-2020)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1567-01 100 mg 1 Blisteris, 6 tablete -
V/MRP/08/1567-02 100 mg 1 Blisteris, 10 tablete -
V/MRP/08/1567-03 100 mg 1 Blisteris, 14 tablete -
V/MRP/08/1567-04 100 mg 2 Blisteris, 10 tablete -
V/MRP/08/1567-05 100 mg 2 Blisteris, 14 tablete -
V/MRP/08/1567-06 100 mg 3 Blisteris, 10 tablete -
V/MRP/08/1567-07 100 mg 3 Blisteris, 14 tablete -
V/MRP/08/1567-08 100 mg 5 Blisteris, 10 tablete -
V/MRP/08/1567-09 100 mg 4 Blisteris, 14 tablete -
V/MRP/08/1567-10 100 mg 6 Blisteris, 10 tablete -
V/MRP/08/1567-11 100 mg 5 Blisteris, 14 tablete -
V/MRP/08/1567-12 100 mg 6 Blisteris, 14 tablete -
V/MRP/08/1567-13 100 mg 7 Blisteris, 14 tablete -
V/MRP/08/1567-14 100 mg 10 Blisteris, 10 tablete -
V/MRP/08/1567-15 100 mg 10 Blisteris, 14 tablete -
V/MRP/08/1567-16 100 mg 18 Blisteris, 10 tablete -
V/MRP/08/1567-17 100 mg 20 Blisteris, 10 tablete -
V/MRP/08/1567-18 100 mg 25 Blisteris, 10 tablete -
V/MRP/08/1567-19 100 mg 20 Blisteris, 14 tablete -
V/MRP/08/1567-20 100 mg 30 Blisteris, 10 tablete -
Prazitel 230/20 mg - V/MRP/14/0021 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP52AA51 cats Vairāk

Medicinal product information

Pharmaceutical form: flavoured film-coated tablets
International name (active substance): Praziquantel,Pyrantel embonate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 06-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0021-01 2 Blisteris, 1 tablete -
V/MRP/14/0021-02 4 Blisteris, 1 tablete -
V/MRP/14/0021-03 6 Blisteris, 1 tablete -
V/MRP/14/0021-04 8 Blisteris, 1 tablete -
V/MRP/14/0021-05 10 Blisteris, 1 tablete -
V/MRP/14/0021-06 12 Blisteris, 1 tablete -
V/MRP/14/0021-07 14 Blisteris, 1 tablete -
V/MRP/14/0021-08 16 Blisteris, 1 tablete -
V/MRP/14/0021-09 18 Blisteris, 1 tablete -
V/MRP/14/0021-10 20 Blisteris, 1 tablete -
V/MRP/14/0021-11 24 Blisteris, 1 tablete -
V/MRP/14/0021-12 28 Blisteris, 1 tablete -
V/MRP/14/0021-13 30 Blisteris, 1 tablete -
V/MRP/14/0021-14 32 Blisteris, 1 tablete -
V/MRP/14/0021-15 36 Blisteris, 1 tablete -
V/MRP/14/0021-16 40 Blisteris, 1 tablete -
V/MRP/14/0021-17 42 Blisteris, 1 tablete -
V/MRP/14/0021-18 44 Blisteris, 1 tablete -
V/MRP/14/0021-19 48 Blisteris, 1 tablete -
V/MRP/14/0021-20 50 Blisteris, 1 tablete -
Canicaral vet 40 mg V/DCP/15/0021 Le Vet Beheer B.V., Nīderlande QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0021-01 40 mg 1 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-02 40 mg 2 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-03 40 mg 3 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-04 40 mg 4 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-05 40 mg 5 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-06 40 mg 6 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-07 40 mg 7 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-08 40 mg 8 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-09 40 mg 9 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-10 40 mg 10 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-11 40 mg 25 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-12 40 mg 50 PA/Al/PVH//Al blisteris, 10 tablete -
Canicaral vet 160 mg V/DCP/15/0022 Le Vet Beheer B.V., Nīderlande QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0022-01 160 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-02 160 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-03 160 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-04 160 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-05 160 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-06 160 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-07 160 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-08 160 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-09 160 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-10 160 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-11 160 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-12 160 mg 50 Al/OPA/Al/PVH blisteris, 10 tablete -
Cevaxel-RTU 50 mg/ml V/DCP/11/0014 Ceva Sante Animale', Francija QJ01DD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ceftiofur (as ceftiofur hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale., Francija
Date of authorisation/renewal: 29-Dec-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0014-01 50 mg/ml 1 Plastmasas pudele, 100 ml -
V/DCP/11/0014-02 50 mg/ml 1 Plastmasas pudele, 250 ml -
V/DCP/11/0014-03 50 mg/ml 1 Plastmasas pudele, 50 ml -
Ubroseal blue Dry Cow 2.6 g V/DCP/18/0004 Univet Ltd., Īrija QG52X cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Bismuth subnitrate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Univet Ltd., Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Nov-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Nov-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0004-01 2,6 g 20 Injektors, 1 deva -
V/DCP/18/0004-02 2,6 g 60 Injektors, 1 deva -
V/DCP/18/0004-03 2,6 g 120 Injektors, 1 deva -
Doxybactin vet 50 mg V/DCP/17/0031 Dechra Regulatory B.V., Nīderlande QJ01AA02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycyclin hyclate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0031-01 50 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-02 50 mg 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-03 50 mg 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-04 50 mg 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-05 50 mg 10 Kastīte ar blisteri, 10 tablete -
Doxybactin vet 200 mg V/DCP/17/0032 Dechra Regulatory B.V., Nīderlande QJ01AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycyclin hyclate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0032-01 200 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-02 200 mg 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-03 200 mg 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-04 200 mg 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-05 200 mg 10 Kastīte ar blisteri, 10 tablete -
Doxybactin vet 400 mg V/DCP/17/0033 Dechra Regulatory B.V., Nīderlande QJ01AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycyclin hyclate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0033-01 400 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-02 400 mg 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-03 400 mg 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-04 400 mg 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-05 400 mg 10 Kastīte ar blisteri, 10 tablete -
Respisure 1 One - V/NRP/03/1567 Elanco GmbH, Vācija QI09AB13 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Mycoplasma hyopneumoniae, strain NL1042, inactivated
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios SYVA S.A., Spānija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1567-02 10 Flakons, 50 deva -
V/NRP/03/1567-03 4 Flakons, 125 deva -
SELIVERM 15 mg V/DCP/24/0045 Bioveta, a.s., Čehija QP54AA05 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Selamectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 27-Jun-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (10-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0045-01 3 Tūbiņa(Alu/PE) ar PP elastomēra uzgali, 0,25 ml -
V/DCP/24/0045-02 6 Tūbiņa(Alu/PE) ar PP elastomēra uzgali, 0,25 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy